Literature DB >> 32773500

Final frontiers of the polio eradication endgame.

Ananda S Bandyopadhyay1, Grace R Macklin2.   

Abstract

PURPOSE OF REVIEW: Focusing on the key developments since January 2019, this review aims to inform policymakers and clinical practitioners on the latest on evolving global polio epidemiology and scientific advancements to guide strategies for eradication. RECENT
FINDINGS: An upsurge in wild poliovirus type 1 cases in Pakistan and Afghanistan and an expansion of type 2 circulating vaccine-derived poliovirus transmission in multiple countries threaten the remarkable progress made over past several decades by the global eradication program. These challenges have also spurred innovation on multiple fronts, including earlier detection, enhanced environmental surveillance and safer and more affordable vaccine options.
SUMMARY: A concerted effort to adapt program strategies to address context-specific challenges and continued focus on innovations to enhance detection and response capabilities will be the key to achieve and sustain eradication of all types of polioviruses.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32773500     DOI: 10.1097/QCO.0000000000000667

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  5 in total

1.  Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.

Authors:  Ethel D Weld; Jacqueline Astemborski; Gregory D Kirk; Mark S Sulkowski; Stephanie Katz; Richard Rothman; Sunil S Solomon; Gail V Matthews; Yu Hsiang Hsieh; Malvika Verma; Giovanni Traverso; Susan Swindells; Andrew Owen; Jordan Feld; Charles Flexner; Shruti H Mehta; David L Thomas
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Plasma cell immunoglobulin heavy chain repertoire dynamics before and after tetanus booster vaccination.

Authors:  Kyle J Wolf; Adebowale A Adeyemo; Kim C Williamson
Journal:  Immunogenetics       Date:  2021-03-25       Impact factor: 3.330

3.  Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication.

Authors:  Ananda S Bandyopadhyay; Walter A Orenstein
Journal:  J Pediatric Infect Dis Soc       Date:  2022-01-27       Impact factor: 3.164

4.  VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen.

Authors:  Erica D Dawson; Amber W Taylor; James E Johnson; Tianjing Hu; Caitlin McCormick; Keely N Thomas; Rachel Y Gao; Rahnuma Wahid; Kutub Mahmood; Kathy L Rowlen
Journal:  J Immunol Methods       Date:  2022-03-18       Impact factor: 2.287

5.  Safeguarding vaccine production and supply strategies for polio eradication endgame.

Authors:  Ananda S Bandyopadhyay; Miguel O'Ryan
Journal:  Lancet Reg Health West Pac       Date:  2021-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.